MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. [electronic resource]
Producer: 20080416Description: 669-74 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Anthracyclines -- pharmacology
- Antibiotics, Antineoplastic -- pharmacology
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- Drug Resistance, Neoplasm
- ErbB Receptors -- analysis
- Female
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Middle Aged
- Mitogen-Activated Protein Kinases -- analysis
- Neoplasm Recurrence, Local -- chemistry
- Odds Ratio
- Phosphatidylinositol 3-Kinases -- analysis
- Prognosis
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Up-Regulation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.